Akebia Therapeutics (NASDAQ:AKBA) Coverage Initiated at Jefferies Financial Group
Jefferies Financial Group assumed coverage on shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm issued a buy rating and a $6.00 target price on the biopharmaceutical company’s stock. AKBA has been the topic of a number of other reports. HC Wainwright restated […]
Jefferies Financial Group assumed coverage on shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. The firm issued a buy rating and a $6.00 target price on the biopharmaceutical company’s stock. AKBA has been the topic of a number of other reports. HC Wainwright restated […]
